Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-019462
Filing Date
2022-04-12
Accepted
2022-04-12 17:15:47
Documents
81
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_nanomixcorp.htm   iXBRL 10-K 1390502
2 DESCRIPTION OF SECURITIES OF NANOMIX CORPORATION f10k2021ex4-27_nanomix.htm EX-4.27 28744
3 DEVELOPMENT AND LICENSE AGREEMENT, DATED SEPTEMBER 26, 2017 BY AND BETWEEN REDPH f10k2021ex10-23_nanomix.htm EX-10.23 183844
4 FIRST AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT, DATED SEPTEMBER 1, 2018 BY f10k2021ex10-24_nanomix.htm EX-10.24 37376
5 LIST OF SUBSIDIARIES f10k2021ex21-1_nanomix.htm EX-21.1 2486
6 CERTIFICATION f10k2021ex31-1_nanomix.htm EX-31.1 10638
7 CERTIFICATION f10k2021ex31-2_nanomix.htm EX-31.2 10502
8 CERTIFICATION f10k2021ex32-1_nanomix.htm EX-32.1 4936
9 CERTIFICATION f10k2021ex32-2_nanomix.htm EX-32.2 4853
10 GRAPHIC image_001.jpg GRAPHIC 28131
  Complete submission text file 0001213900-22-019462.txt   6643093

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE nnmx-20211231.xsd EX-101.SCH 77981
12 XBRL CALCULATION FILE nnmx-20211231_cal.xml EX-101.CAL 35461
13 XBRL DEFINITION FILE nnmx-20211231_def.xml EX-101.DEF 303021
14 XBRL LABEL FILE nnmx-20211231_lab.xml EX-101.LAB 594859
15 XBRL PRESENTATION FILE nnmx-20211231_pre.xml EX-101.PRE 314799
75 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_nanomixcorp_htm.xml XML 626467
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
NANOMIX Corp (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 22822975
SIC: 2834 Pharmaceutical Preparations